| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Atlas Venture Opportunity Fund I, L.P. is a 10% Owner at Dyne Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $47.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | DYN Dyne Therapeutics, Inc. | 10% Owner | Sell | 46,534 | $30.05 | $1,398,346.70 | -2.0% | +7.1% | -53.3% |